USCG releases RfP for lifeboat life extension
The US Coast Guard released a request for proposal (RfP) on 21 November for services and supplies for its 47ft motor lifeboat (MLBs) service life extension programme as part of in-service vessel sustainment.
The coast guard plans to award one firm-fixed price indefinite delivery indefinite quantity contract, which will have an ordering period of ten years from date of contract award.
The fleet of over 100 MLBs has been in service for 15 to 21 years and is approaching the end of its planned 25-year service life. The programme will extend the useful life of the MLB by 20 years and address parts availability and obsolescence issues.
The original operational characteristics and capabilities of the service’s primary search and rescue platform in surf and heavy weather conditions will effectively remain the same, while efforts to enhance human system integration will be made where practical.
More from Naval Warfare
-
Future of the US Navy’s Arleigh Burke programme remains unclear
The US Navy does not have a precise date for the award of the procurement contract for the third Arleigh Burke-class destroyer despite having the funds to advance with the programme in FY2025.
-
US Navy may look to foreign suppliers to accelerate shipbuilding programmes
The US Navy (USN) is currently reassessing its acquisition efforts and seeking ways to reduce the multiple delays across the shipbuilding initiatives.
-
Australia commissions HMAS Arafura three-and-a-half years behind schedule
The Royal Australian Navy has finally commissioned the first Arafura-class offshore patrol vessel – more than three years behind schedule – highlighting the programme’s delays, design compromises and ongoing industrial restructuring.
-
Italy orders two ships as work begins on others along with deliveries and updates
The Italian Navy is being refreshed with two new ships ordered, while in the past six months steel was cut for a new frigate, an enhanced frigate was delivered and Horizon-class frigates passed a design review.